Close Menu

Sequencing startup Pacific Biosciences was happily handing out copies of the New York Times at the Marco Island meeting on Saturday, and here's why: a couple of articles prominently featured the company and its technology, which it officially unveiled at the AGBT conference. This one surveys the field, mentioning other companies such as Helicos, and quotes a number of top-notch scientists about their views on the PacBio tech.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.